Marta E Bull1, Jillian Legard, Kenneth Tapia, Bess Sorensen, Susan E Cohn, Rochelle Garcia, Sarah E Holte, Robert W Coombs, Jane E Hitti. 1. *Department of Pediatrics, University of Washington, Seattle, WA; †Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA; ‡Department of Global Health, University of Washington, Seattle, WA; §Department of Medicine, University of Rochester Medical Center, Rochester, NY; Departments of ‖Pathology; ¶Medicine, University of Washington, Seattle, WA; #Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; **Department of Laboratory Medicine, University of Washington, Seattle, WA; ††Department of Obstetrics and Gynecology, University of Washington, Seattle, WA (J. Legard is now with the Global Alliance to Prevent Prematurity and Stillbirth Program, Seattle Children's Hospital, Seattle, WA; B. Sorensen is now with Gilead, Seattle, WA; S. E. Cohn is now with the Department of Medicine, Northwestern University, Chicago, IL).
Abstract
BACKGROUND: HIV-1 shedding from the female genital tract is associated with increased sexual and perinatal transmission and has been broadly evaluated in cross-sectional studies. However, few longitudinal studies have evaluated how the immune microenvironment effects shedding. METHODS: Thirty-nine HIV-1-infected women had blood, cervicovaginal lavage, and biopsies of the uterine cervix taken quarterly for up to 5 years. Cytokines/chemokines were quantified by Luminex assay in cervicovaginal lavage, and cellular phenotypes were characterized using immunohistochemistry in cervical biopsies. Comparisons of cytokine/chemokine concentrations and the percent of tissue staining positive for T cells were compared using generalized estimating equations between non-shedding and shedding visits across all women and within a subgroup of women who intermittently shed HIV-1. RESULTS: Genital HIV-1 shedding was more common when plasma HIV-1 was detected. Cytokines associated with cell growth (interleukin-7), Th1 cells/inflammation (interleukin-12p70), and fractalkine were significantly increased at shedding visits compared with non-shedding visits within intermittent shedders and across all subjects. Within intermittent shedders and across all subjects, FOXP3 T cells were significantly decreased at shedding visits. However, there were significant increases in CD8 cells and proportions of CD8FOXP3 T cells associated with HIV-1 shedding. CONCLUSIONS: Within intermittent HIV-1 shedders, decreases in FOXP3 T cells at the shedding visit suggests that local HIV-1 replication leads to CD4 T-cell depletion, with increases in the proportion of CD8FOXP3 cells. HIV-1-infected cell loss may promote a cytokine milieu that maintains cellular homeostasis and increases immune suppressor cells in response to HIV-1 replication in the cervical tissues.
BACKGROUND:HIV-1 shedding from the female genital tract is associated with increased sexual and perinatal transmission and has been broadly evaluated in cross-sectional studies. However, few longitudinal studies have evaluated how the immune microenvironment effects shedding. METHODS: Thirty-nine HIV-1-infectedwomen had blood, cervicovaginal lavage, and biopsies of the uterine cervix taken quarterly for up to 5 years. Cytokines/chemokines were quantified by Luminex assay in cervicovaginal lavage, and cellular phenotypes were characterized using immunohistochemistry in cervical biopsies. Comparisons of cytokine/chemokine concentrations and the percent of tissue staining positive for T cells were compared using generalized estimating equations between non-shedding and shedding visits across all women and within a subgroup of women who intermittently shed HIV-1. RESULTS: Genital HIV-1 shedding was more common when plasma HIV-1 was detected. Cytokines associated with cell growth (interleukin-7), Th1 cells/inflammation (interleukin-12p70), and fractalkine were significantly increased at shedding visits compared with non-shedding visits within intermittent shedders and across all subjects. Within intermittent shedders and across all subjects, FOXP3 T cells were significantly decreased at shedding visits. However, there were significant increases in CD8 cells and proportions of CD8FOXP3 T cells associated with HIV-1 shedding. CONCLUSIONS: Within intermittent HIV-1 shedders, decreases in FOXP3 T cells at the shedding visit suggests that local HIV-1 replication leads to CD4 T-cell depletion, with increases in the proportion of CD8FOXP3 cells. HIV-1-infected cell loss may promote a cytokine milieu that maintains cellular homeostasis and increases immune suppressor cells in response to HIV-1 replication in the cervical tissues.
Authors: Caroline Mitchell; Jane Hitti; Kathleen Paul; Kathy Agnew; Susan E Cohn; Amneris E Luque; Robert Coombs Journal: AIDS Res Hum Retroviruses Date: 2010-10-07 Impact factor: 2.205
Authors: S D Lawn; S Subbarao; T C Wright; T Evans-Strickfaden; T V Ellerbrock; J L Lennox; S T Butera; C E Hart Journal: J Infect Dis Date: 2000-05-31 Impact factor: 5.226
Authors: Catherine A Blish; Ozge C Dogan; Walter Jaoko; R Scott McClelland; Kishorchandra Mandaliya; Katherine S Odem-Davis; Barbra A Richardsonb; Julie Overbaugh Journal: AIDS Date: 2012-03-13 Impact factor: 4.177
Authors: P A Crowley-Nowick; J H Ellenberg; S H Vermund; S D Douglas; C A Holland; A B Moscicki Journal: J Infect Dis Date: 2000-03 Impact factor: 5.226
Authors: M Suthanthiran; B Li; J O Song; R Ding; V K Sharma; J E Schwartz; P August Journal: Proc Natl Acad Sci U S A Date: 2000-03-28 Impact factor: 11.205
Authors: Y Lévy; I Sereti; G Tambussi; J P Routy; J D Lelièvre; J F Delfraissy; J M Molina; M Fischl; C Goujard; B Rodriguez; C Rouzioux; V Avettand-Fenoël; T Croughs; S Beq; M Morre; J F Poulin; R P Sekaly; R Thiebaut; M M Lederman Journal: Clin Infect Dis Date: 2012-05-01 Impact factor: 9.079
Authors: Craig R Cohen; Jairam R Lingappa; Jared M Baeten; Musa O Ngayo; Carol A Spiegel; Ting Hong; Deborah Donnell; Connie Celum; Saidi Kapiga; Sinead Delany; Elizabeth A Bukusi Journal: PLoS Med Date: 2012-06-26 Impact factor: 11.069
Authors: LaShonda Y Spencer; Shawna Christiansen; Chia-Hao H Wang; Wendy J Mack; Mary Young; Howard D Strickler; Kathryn Anastos; Howard Minkoff; Mardge Cohen; Ruth M Geenblatt; Roksana Karim; Eva Operskalski; Toni Frederick; James D Homans; Alan Landay; Andrea Kovacs Journal: J Acquir Immune Defic Syndr Date: 2016-02-01 Impact factor: 3.731
Authors: Julie A E Nelson; Kristina De Paris; Catalina Ramirez; Andrew Edmonds; Katie R Mollan; Camden P Bay; Kara Compliment; Betsy C Herold; Kathryn Anastos; Howard Minkoff; Seble Kassaye; Dominika L Seidman; Audrey L French; Elizabeth T Golub; Anandi N Sheth; Christina Ochsenbauer; Ronald Swanstrom; Joseph J Eron; Adaora A Adimora Journal: AIDS Date: 2020-01-01 Impact factor: 4.632
Authors: Smita S Iyer; Michael J Sabula; C Christina Mehta; Lisa B Haddad; Nakita L Brown; Rama R Amara; Igho Ofotokun; Anandi N Sheth Journal: PLoS One Date: 2017-06-01 Impact factor: 3.240
Authors: Laura Pattacini; Amanda Woodward Davis; Julie Czartoski; Florian Mair; Scott Presnell; Sean M Hughes; Ollivier Hyrien; Gretchen M Lentz; Anna C Kirby; Michael F Fialkow; Florian Hladik; Martin Prlic; Jennifer M Lund Journal: Mucosal Immunol Date: 2019-07-16 Impact factor: 8.701